Proactive Investors - Run By Investors For Investors

Namaste Technologies says two board members, Kiran Sidhu and Sefi Dollinger step down

Kiran Sidhu and Sefi Dollinger are leaving the cannabis company's board
cannabis plant
Toronto-based Namaste, which has been described as the “Amazon of cannabis,” operates the largest global cannabis e-commerce platform

Namaste Technologies Inc (CVE:N) (OTCMKTS:NXTTF) said Thursday that Kiran Sidhu and Sefi Dollinger have resigned from its board to pursue other interests.

In the wake of Sidhu and Dollinger’s departures, the Canadian cannabis company is looking to add up to two independent directors and is holding discussions with potential candidates.

READ: Namaste Technologies looks to become the ‘Amazon of cannabis’ with its integrated, intelligent cannabis experience

Namaste’s board is now made up of Laurens Feenstra, Kenneth Ngo and Branden Spikes, former chief information officer at Elon Musk’s SpaceX, who serves as chairman.

Toronto-based Namaste, which has been described as the “Amazon of cannabis,” operates the largest global cannabis e-commerce platform with over 30 websites in more than 20 countries under a variety of brands.

READ: Namaste sees green in edibles, buys a stake in Choklat for C$1.5M

In addition to its product offerings of vaporizers, glassware, accessories and CBD products, the company is also involved in the world of medical cannabis, through its licensed subsidiary CannMart Inc, not to mention its efforts in artificial intelligence, cannabis strain research and a global telemedicine app, as well as the sales of medical cannabis from its facility in Toronto.

Namaste shares slipped C$0.12 to finish at C$0.76 on Wednesday.

Contact Ellen Kelleher at [email protected]

View full N profile View Profile

Namaste Technologies Inc Timeline

Related Articles

1550850611_CancerHeadline.jpg
February 22 2019
Broker Hybridan reckons Sareum is “arguably a bargain target for the relatively large group of biotech and pharma companies interested in TYK2 and the wider JAK inhibitor space”
test tubes
April 16 2019
Summit Therapeutics' potential breakthrough targets C.difficile
genedrive device
Thu
Here we take a closer look at Genedrive PLC (LON:GDR)
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use